First‑in‑human phase 1/2a study launches in China and the US targeting advanced cancers
New funding will support the phase 2 expansion trial of THEO-260
Updated Date: Tue, 24 Feb 2026 00:00:00 EST
Updated Date: Tue, 24 Feb 2026 00:00:00 EST
Updated Date: Tue, 24 Feb 2026 00:00:00 EST
Updated Date: Tue, 24 Feb 2026 00:00:00 EST
A proposal to make newly qualified doctors, dentists, and nurses work in the NHS in Scotland for at […]
A formula milk company involved in a recent contamination outbreak has hiked its prices despite concerns that they […]
DementAI prototype developed by Katalyze Data seeks to ease pressure on clinical teams
Company targets new approach to treating rheumatoid arthritis and systemic sclerosis